Main Article Content
Abstract
Medicines are an integral part of healthcare delivery systems. However, they are expensive commodities and account for a significant proportion of overall health expenditure in most countries. The irrational use of medicines is a major challenge faced by many health systems worldwide. Unfortunately, more than 50% of medications are prescribed, dispensed, and sold irrationally. Additionally, over 50% of patients do not use their medications correctly. The aim of this study is to review the issue of irrational medicine use, based on a comprehensive review of credible scientific literature. The study concludes that irrational use of medicines persists in many countries, including Afghanistan. Fortunately, some measures have been adopted to address this problem. However, due to the widespread nature of the issue, these actions are insufficient, and more comprehensive efforts are required to tackle the problem effectively.
Keywords
Article Details
Copyright (c) 2024 Reserved for Kabul University.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
- Sebsibie G, and Gultie T. Retrospective assessment of irrational use of antibiotics to children attending in Mekelle general hospital. Sci J of Clin Med. 2014; 3:46-51.
- Management Sciences for Health (MSH). Managing access to medicines and health technologies MDS-3). 2012; 27.2.-27.8.
- Kadyrova N, Wanning B, & Cashin C. “Kyrgyzstan outpatient drug (OPD) benefit program: use of automated claims data to evaluate the impact of OPD benefit program on rational drug prescribing by physicians and generic drug use by patients” ICUM 2004 conference, March30-April 2, Chiang Mai Thalland.2004.
- WHO/TCM (world health organization/technical cooperation for essential drugs and traditional medicine). Medicine use in primary care in developing and traditional countries: fact book summarizing results from studies reported between 1990 and 2006. Geneva. WHO. 2009, available from http://whqlibdoc.who.int/hq/2009/WHO_EMP_MAR_2009.3_eng.pdf.
- Trap B, and Hansen EH. Dispensing prescribers----A threat to appropriate medicine use? Ess Drugs Mon. 2003; 32:9.
- Gossems. HM, Ferech R. Vander Stichele, & Elseviers M. Outpatient Antibiotic use in Europe and Association with resistance: A Cross National Database study. The Lancet. 2005;365:579-87.
- WHO (world health organization). Medicines: rational use of medicines. Factsheet no: 338. Geneva. WHO. 2010 available from http://www.who.int/mediacentre/factsheets/fs338/en/
- Patel, VR Vaidya DN, & Borker P. Irrational drug use in India. A prescription survey from Goa. Journal of postgraduate medicine. 2005; 51(1); 9-12.
- Deymttenaere, KR Bruffaerts, J. Posada-Villa,I.Gasquet,. KovessV, Epine JPL, & et al. Prevalence, severity and unmet need for treatment of mental disorders in the world health organization world mental health surveys. Journal of American Medical association; 2004;29(21): Pp:2581-90.
- SCORE (strategic council on resistance in Europe). Resistance a sensitive issue. Utrecht: SCORE. 2004.
- Holloway KA, Gautam BR, & Reeves BC. (2001)..The effects of different kinds of user fee on prescribing costs in rural Nepal. Health policy and Planning.2001;16:421-7.
- Arrow KJCB, Panosian C, & Gelband H. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance Washington, D.C.: National academy press for institute of medicine. 2004; PMID: 25009879.https://medipense.com/accessed 27 November 2021.
References
Sebsibie G, and Gultie T. Retrospective assessment of irrational use of antibiotics to children attending in Mekelle general hospital. Sci J of Clin Med. 2014; 3:46-51.
Management Sciences for Health (MSH). Managing access to medicines and health technologies MDS-3). 2012; 27.2.-27.8.
Kadyrova N, Wanning B, & Cashin C. “Kyrgyzstan outpatient drug (OPD) benefit program: use of automated claims data to evaluate the impact of OPD benefit program on rational drug prescribing by physicians and generic drug use by patients” ICUM 2004 conference, March30-April 2, Chiang Mai Thalland.2004.
WHO/TCM (world health organization/technical cooperation for essential drugs and traditional medicine). Medicine use in primary care in developing and traditional countries: fact book summarizing results from studies reported between 1990 and 2006. Geneva. WHO. 2009, available from http://whqlibdoc.who.int/hq/2009/WHO_EMP_MAR_2009.3_eng.pdf.
Trap B, and Hansen EH. Dispensing prescribers----A threat to appropriate medicine use? Ess Drugs Mon. 2003; 32:9.
Gossems. HM, Ferech R. Vander Stichele, & Elseviers M. Outpatient Antibiotic use in Europe and Association with resistance: A Cross National Database study. The Lancet. 2005;365:579-87.
WHO (world health organization). Medicines: rational use of medicines. Factsheet no: 338. Geneva. WHO. 2010 available from http://www.who.int/mediacentre/factsheets/fs338/en/
Patel, VR Vaidya DN, & Borker P. Irrational drug use in India. A prescription survey from Goa. Journal of postgraduate medicine. 2005; 51(1); 9-12.
Deymttenaere, KR Bruffaerts, J. Posada-Villa,I.Gasquet,. KovessV, Epine JPL, & et al. Prevalence, severity and unmet need for treatment of mental disorders in the world health organization world mental health surveys. Journal of American Medical association; 2004;29(21): Pp:2581-90.
SCORE (strategic council on resistance in Europe). Resistance a sensitive issue. Utrecht: SCORE. 2004.
Holloway KA, Gautam BR, & Reeves BC. (2001)..The effects of different kinds of user fee on prescribing costs in rural Nepal. Health policy and Planning.2001;16:421-7.
Arrow KJCB, Panosian C, & Gelband H. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance Washington, D.C.: National academy press for institute of medicine. 2004; PMID: 25009879.https://medipense.com/accessed 27 November 2021.